Official EU label nameGlossary entry 24115

RESVERATROL

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:501-36-0

EC:610-504-8

Ingredient index records:

RESVERATROL

Cosmetic functions: ANTIOXIDANT, SKIN PROTECTING

1,3-Benzenediol, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-

Open full local profile

1 matched or reported name

RESVERATROL

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name RESVERATROL.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 501-36-0

CAS 501-36-0PubChem CID 445154

Resveratrol

Resveratrol is a plant polyphenol found in high concentrations in red grapes that has been proposed as a treatment for hyperlipidemia and to prevent fatty liver, diabetes, atherosclerosis and aging. Resveratrol use has been associated with rare instances of serum enzyme elevations during therapy but has not been convincingly linked to episodes of clinically apparent liver injury. — LiverTox

IUPAC name: 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol

Molecular formula: C14H12O3
Molecular weight: 228.24 g/mol
Exact mass: 228.078644241 Da
XLogP3: 3.1
Topological polar surface area: 60.7 Å²
Hydrogen-bond donors: 3
Hydrogen-bond acceptors: 3
Covalent units: 1
Defined stereocentres: 0

Also known as

trans-resveratrol3,4',5-Trihydroxystilbene(E)-resveratrolResvida3,4',5-Stilbenetriol3,4',5-Trihydroxy-trans-stilbeneBiofortCuspidatin

16 more reported names

5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediolJotrolSRT-501(E)-5-(p-Hydroxystyryl)resorcinolResveratrol p 5SRT501Melinjo resveratrol 20Srt 501m5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diolNSC-327430Q369O8926LCHEBI:27881CHEBI:45713Ca 1201BIA 6-512BIA-6-512

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:27881
ChEBI:CHEBI:45713
ChEMBL:CHEMBL165
EPA DTXSID:DTXSID4031980
PubMed:32020584
PubMed:29095837
PubMed:28883751
PubMed:28810692
PubMed:28338176
PubMed:26328004
PubMed:26099829
PubMed:25788047
PubMed:25701602
PubMed:25652123
PubMed:25525597
PubMed:25451966

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision